NEW YORK--(BUSINESS WIRE)--The Law Offices of Vincent Wong are investigating the Board of Directors of iKang Healthcare Group, Inc. (“iKang” or the “Company”) (NASDAQGS:KANG) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to a consortium of entities led by CEO and Chairman Lee Ligang Zhang and Vice Chairman of the Board Boquan He. Under the terms of the transaction, iKang shareholders will receive US$41.20 per Class A or Class C common share and US$20.60 per American depositary share. Mr. Zhang and Mr. Boquan have agreed to tender their shares, representing approximately 25.6% of the Company’s outstanding shares and approximately 43.1% of total voting power of the outstanding shares.
The investigation concerns whether the iKang Board of Directors breached their fiduciary duties to iKang stockholders by failing to adequately shop the Company before entering into this transaction and whether the consortium is underpaying for iKang shares, thus unlawfully harming iKang stockholders.
If you own common stock in iKang and wish to obtain additional information, please contact Vincent Wong, Esq. either via email firstname.lastname@example.org, by telephone at 212.425.1140, or http://docs.wongesq.com/KANG-Info-Request-Form-1869.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.